ObsEva (NASDAQ:OBSV) Now Covered by StockNews.com

Equities researchers at StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued on Sunday. The brokerage set a “hold” rating on the stock.

ObsEva Price Performance

NASDAQ:OBSV opened at $0.01 on Friday. The business’s 50-day simple moving average is $0.02 and its 200-day simple moving average is $0.04. ObsEva has a fifty-two week low of $0.08 and a fifty-two week high of $2.14. The stock has a market capitalization of $389,855.00, a PE ratio of -0.01 and a beta of 0.68.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.